The gut-masticatory muscles-temporomandibular joint pain axis—a scoping review

Orofacial pain has become the most common debilitating disease resulting in high healthcare costs, and compromising the quality of life, speech, aesthetics and masticatory function of those affected. As its aetiology is multifactorial and as the treatment involves a multidisciplinary holistic approach, arriving at a confirmative diagnosis is challenging. Numerous studies have been published that support the bidirectional link between gut health and other organs like the cardiovascular system, respiratory system, neurological and hormonal. Recent studies indicate a potential link between gut microbiota dysbiosis and chronic orofacial and temporomandibular joint (TMJ) pain. In this review, we enumerate the link between the metabolites released by the gut bacteria and how they regulate the pain mechanism of various types of orofacial pain like chronic, neuropathic and inflammatory in the orofacial and TMJ regions. We also discuss the potential link between pain and gender predisposition. Further, we review the recent non-invasive therapeutic options which can be put forth to use for treating orofacial and TMJ pain.

Orofacial pain; Temporomandibular joint; Microbiome; Probiotics; Brain-gut axis

[1] Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018; 67: 1716–1725.

[2] Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007; 449: 804–810.

[3] Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, et al. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacological Research. 2021; 172: 105840.

[4] Quigley EMM. Microbiota-brain-gut axis and neurodegenerative diseases. Current Neurology and Neuroscience Reports. 2017; 17: 94.

[5] Chen J, Wang Q, Wang A, Lin Z. Structural and functional characterization of the GM in elderly women with migraine. Frontiers in Cellular and Infection Microbiology. 2020; 9: 470.

[6] Harper DE, Schrepf A, Clauw DJ. Pain mechanisms and centralized pain in temporomandibular disorders. Journal of Dental Research. 2016; 95: 1102–1108.

[7] Mayer EA, Nance K, Chen S. The gut-brain axis. Annual Review of Medicine. 2022; 73: 439–453.

[8] Lassmann Ł, Pollis M, Żółtowska A, Manfredini D. Gut bless your pain-roles of the gm, sleep, and melatonin in chronic orofacial pain and depression. Biomedicines. 2022; 10: 1528.

[9] Tang Y, Liu S, Shu H, Yanagisawa L, Tao F. GM dysbiosis enhances migraine-like pain via TNF-α upregulation. Molecular Neurobiology. 2020; 57: 461–468.

[10] Bolaños MD, Zumba EG, Rodríguez ML. Burning mouth syndrome as a manifestation of an unbalanced psycho-neuro-immuno-endocrine axis in mentally ill women with intestinal dysbiosis: a literature review. World Journal of Advanced Research and Reviews. 2022; 14: 040–050.

[11] Li JS, Su SL, Xu Z, Zhao LH, Fan RY, Guo JM. Potential roles of GM and microbial metabolites in chronic inflammatory pain and the mechanisms of therapy drugs. Therapeutic Advances in Chronic Disease. 2022; 13: 20406223221091177.

[12] Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009; 139: 267–284.

[13] Guo R, Chen LH, Xing C, Liu T. Pain regulation by GM: molecular mechanisms and therapeutic potential. British Journal of Anaesthesia. 2019; 123: 637–654.

[14] Chiang CY, Sessle BJ, Dostrovsky JO. Role of astrocytes in pain. Neurochemical Research. 2012; 37: 2419–2431.

[15] Sessle BJ. Peripheral and central mechanisms of orofacial inflammatory pain. International Review of Neurobiology. 2011; 97: 179–206.

[16] Ji RR, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013; 154: S10–S28.

[17] Zhang ZJ, Jiang BC, Gao YJ. Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. Cellular and Molecular Life Sciences. 2017; 74: 3275–3291.

[18] Donnelly CR, Andriessen AS, Chen G, Wang K, Jiang C, Maixner W, et al. Central nervous system targets: glial cell mechanisms in chronic pain. Cellular and Molecular Life Sciences. 2020; 17: 846–860.

[19] Bradesi S, Svensson CI, Steinauer J, Pothoulakis C, Yaksh TL, Mayer EA. Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stress. Gastroenterology. 2009; 136: 1339–1348.

[20] Magni G, Riboldi B, Ceruti S. Modulation of glial cell functions by the Gut-Brain Axis: a role in neurodegenerative disorders and pain transmission. Cells. 2023; 12: 1612.

[21] Martins DO, Marques DP, Venega RAG, Chacur M. Photobiomodulation and B vitamins administration produces antinociception in an orofacial pain model through the modulation of glial cells and cytokines expression. Brain Behavior Immunity Health. 2020; 2: 100040.

[22] Zhang JD, Liu J, Zhu SW, Fang Y, Wang B, Jia Q, et al. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation. Acta Pharmacologica Sinica. 2021; 42: 1821–1833.

[23] Valesan LF, Da-Cas CD, Réus JC, Denardin ACS, Garanhani RR, Bonotto D, et al. Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis. Clinical Oral Investigations. 2021; 25: 441–453.

[24] Munzenmaier DH, Wilentz J, Cowley AW III. Genetic, epigenetic, and mechanistic studies of temporomandibular disorders and overlapping pain conditions. Molecular Pain. 2014; 10: 72.

[25] Gallotta S, Bruno V, Catapano S, Mobilio N, Ciacci C, Iovino P. High risk of temporomandibular disorder in irritable bowel syndrome: is there a correlation with greater illness severity? World Journal of Gastroenterology. 2017; 23: 103–109.

[26] Versteeg RI, Serlie MJ, Kalsbeek A, la Fleur SE. Serotonin, a possible intermediate between disturbed circadian rhythms and metabolic disease. Neuroscience. 2015; 301: 155–167.

[27] Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. The Microbiome-Gut-Brain Axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry. 2013; 18: 666–673.

[28] Ridaura V, Belkaid Y. GM: the link to your second brain. Cell. 2015; 161: 193–194.

[29] Li Y, Fang M, Niu L, Fan Y, Liu Y, Long Y, et al. Associations among gastroesophageal reflux disease, mental disorders, sleep and chronic temporomandibular disorder: a case-control study. Canadian Medical Association Journal. 2019; 191: E909–E915.

[30] Zhou F, Wang X, Han B, Tang X, Liu R, Ji Q, et al. Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Molecular Pain. 2021; 17: 1744806921996520.

[31] Nagamine T. Burning mouth syndrome needs to consider the gut-brain axis from three types of pain: nociceptive, neuropathic, and nociplastic pain. Journal of Gastrointestinal and Liver Diseases. 2023; 32: 558–559.

[32] Lan Z, Wei Y, Yue K, He R, Jiang Z. Genetically predicted immune cells mediate the association between gut microbiota and neuropathy pain. Inflammopharmacology. 2024; 32: 3357–3373.

[33] Murakami N, Yoshikawa K, Tsukada K, Kamio N, Hayashi Y, Hitomi S, et al. Butyric acid modulates periodontal nociception in Porphyromonas gingivalis-induced periodontitis. Journal of Oral Science. 2022; 64: 91–94.

[34] Ma Y, Liu S, Shu H, Crawford J, Xing Y, Tao F. Resveratrol alleviates temporomandibular joint inflammatory pain by recovering disturbed GM. Brain Behavior and Immunity. 2020; 87: 455–464.

[35] Li XY, Yang CH, Lv JJ, Liu H, Zhang LY, Yin MY, et al. Global, regional, and national epidemiology of migraine and tension-type headache in youths and young adults aged 15–39 years from 1990 to 2019: findings from the global burden of disease study 2019. The Journal of Headache and Pain. 2023; 24: 126.

[36] Jones R, Lydeard S. Irritable bowel syndrome in the general population. British Medical Journal. 1992; 304: 87–90.

[37] Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Alimentary Pharmacology & Therapeutics. 2004; 20: 1195–1203.

[38] Peatfield RC, Glover V, Littlewood JT, Sandler M, Clifford Rose F. The prevalence of diet-induced migraine. Cephalalgia. 1984; 4: 179–183.

[39] van Hemert S, Breedveld AC, Rovers JM, Vermeiden JP, Witteman BJ, Smits MG, et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Frontiers in Neurology. 2014; 5: 241.

[40] Aamodt AH, Stovner LJ, Hagen K, Zwart JA. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT study. Cephalalgia. 2008; 28: 144–151.

[41] Boyle R, Behan PO, Sutton JA. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. British Journal of Clinical Pharmacology. 1990; 30: 405–409.

[42] Bates EA, Nikai T, Brennan KC, Fu YH, Charles AC, Basbaum AI, et al. Sumatriptan alleviates nitroglycerininduced mechanical and thermal allodynia in mice. Cephalalgia. 2010; 30: 170–178.

[43] Tang Y, Liu S, Shu H, Xing Y, Tao F. AMPA receptor GluA1 Ser831 phosphorylation is critical for nitroglycerin-induced migraine- like pain. Neuropharmacology. 2018; 133: 462–469.

[44] Mahmoudi J, Mohaddes G, Erfani M, Sadigh-Eteghad S, Karimi P, Rajabi M, et al. Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats. Brain Research Bulletin. 2018; 140: 197–204.

[45] Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, et al. Plasma cytokine levels in migraineurs and controls. Headache 2005; 45: 926–931.

[46] Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLOS Biology. 2016; 14: e1002533.

[47] Yoon K, Kim N. Roles of sex hormones and gender in the gut microbiota. Journal of Neurogastroenterology and Motility. 2021; 27: 314–325.

[48] Mulak A, Taché Y, Larauche M. Sex hormones in the modulation of irritable bowel syndrome. World Journal of Gastroenterology. 2014; 20: 2433–2448.

[49] Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. Journal of the National Cancer Institute. 2016; 108: djw029.

[50] Caputi V, Bastiaanssen TFS, Peterson V, Sajjad J, Murphy A, Stanton C, et al. Sex, pain, and the microbiome: the relationship between baseline gut microbiota composition, gender and somatic pain in healthy individuals. Brain Behavior and Immunity. 2022; 104: 191–204.

[51] Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine. 2012; 37: E668–E677.

[52] Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behaviour Research and Therapy. 2006; 44: 1–25.

[53] Priyank H, Shankar Prasad R, Shivakumar S, Sayed Abdul N, Pathak A, Cervino G. Management protocols of chronic orofacial pain: a systematic review. Saudi Dental Journal. 2023; 35: 395–402.

[54] Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the probiotic bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010; 170: 1179–1188.

[55] Liang S, Wang T, Hu X, Luo J, Li W, Wu X, et al. Administration of lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience. 2015; 310: 561–577.

[56] Müller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Molecular Psychiatry. 2007; 12: 988–1000.

[57] Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, et al. Consumption of fermented milk product with probiotic modu­lates brain activity. Gastroenterology. 2013; 144: 1394–1401.

[58] Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimina­tion. Alternative Medicine Review. 2001; 6: 488–494.

[59] de Roos NM, Giezenaar CG, Rovers JM, Witteman BJ, Smits MG, van Hemert S. The effects of the multispecies probiotic mix­ture Ecologic®Barrier on migraine: results of an open-label pilot study. Beneficial Microbes. 2015; 6: 641–646.

[60] de Roos NM, van Hemert S, Rovers JMP, Smits MG, Witteman BJM. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized pla­cebo-controlled study. European Journal of Clinical Nutrition. 2017; 71: 1455–1462.

[61] Ghavami A, Khorvash F, Heidari Z, Khalesi S, Askari G. Effect of synbiotic supplementation on migraine characteristics and inflammatory biomarkers in women with migraine: results of a randomized controlled trial. Pharmacological Research. 2021; 169: 105668.

[62] Moens F, Van den Abbeele P, Basit AW, Dodoo C, Chatterjee R, Smith B, et al. A four-strain probiotic exerts positive immuno­modulatory effects by enhancing colonic butyrate production in vitro. International Journal of Pharmaceutics. 2019; 555: 1–10.

[63] Kiecka A, Szczepanik M. Migraine and the microbiota. Can probiotics be beneficial in its prevention?—a narrative review. Pharmacological Reports. 2024; 76: 251–262.

[64] Volta U, Bardella MT, Calabrò A, Troncone R, Corazza GR; Study Group for Non-Celiac Gluten Sensitivity. Study Group for non-celiac gluten sensitivity. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Medicine. 2014; 12: 85.

[65] Araújo Oliveira Buosi J, Abreu Nogueira SM, Sousa MP, Soraya Costa Maia C, Regis RR, de Freitas Pontes KM, et al. Gluten-free diet reduces pain in women with myofascial pain in masticatory muscles: a preliminary randomized controlled trial. Journal of Oral & Facial Pain and Headache. 2021; 35: 199–207.

[66] Costantini L, Molinari R, Farinon B, Merendino N. Impact of Omega-3 fatty acids on the gut microbiota. International Journal of Molecular Sciences. 2017; 18: 2645.

[67] Li JG, Lin JJ, Wang ZL, Cai WK, Wang PN, Jia Q, et al. Melatonin attenuates inflammation of acute pulpitis subjected to dental pulp injury. American Journal of Translational Research. 2015; 7: 66–78.

[68] Scarabelot VL, Medeiros LF, de Oliveira C, Adachi LN, de Macedo IC, Cioato SG, et al. Melatonin alters the mechanical and thermal hyperalgesia induced by orofacial pain model in rats. Inflammation. 2016; 39: 1649–1659.

[69] Vidor LP, Torres IL, Custódio de Souza IC, Fregni F, Caumo W. Analgesic and sedative effects of melatonin in temporomandibular disorders: a double-blind, randomized, parallel-group, placebo-controlled study. Journal of Pain and Symptom Management. 2013; 46: 422–432.

[70] Erden S. Sleep-related bruxism response to melatonin Treatment. Journal of Child and Adolescent Psychopharmacology. 2020; 30: 201.

[71] Zheng L, Shen J, Chen R, Hu Y, Zhao W, Leung EL, et al. Genome engineering of the human gut microbiome. Journal of Genetics and Genomics. 2024; 51: 479–491.

[72] Nijs J, George SZ, Clauw DJ, Fernández-de-Las-Peñas C, Kosek E, Ickmans K, et al. Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. The Lancet Rheumatology. 2021; 3: e383–e392.